In patients with T2D, insulin resistance is a product of decreased insulin-stimulated skeletal muscle glycogen synthesis, which can mostly be attributed to decreased insulin-stimulated glucose transport (Glut 4) activity [79] and similar alterations have been observed in maternal skeletal muscle in GDM [80, 81]. This evidence concerns the gene INS and type 2 diabetes mellitus.